Cannabis Law Report

JANUARY 18, 2022

.–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. Mack, Chairman and CEO of Virpax.

Safety 40

Safety Chronic Pain Research and Development Pharmaceutical 40

NORML

FEBRUARY 1, 2019

The measure would expand the pool of individuals eligible for medical cannabis by allowing physicians to recommend it to those with generalized chronic pain. Click here to email your lawmakers in support of adding chronic pain to the qualifying medical conditions list. CT resident? NH resident?

Legislation 188

Legislation Decriminalization Access Patients 188

Veriheal

NOVEMBER 10, 2020

The experiment will allow participating companies to import cannabis and the companies who wish to participate in the experiment will be obliged to give participants free medical cannabis which has to comply with the pharmaceutical standards and good manufacturing practice. .

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

MAY 17, 2021

Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” She ends the column by stating “ I urge our legislators to abandon this legislation for the sake of our citizen’s health and safety.”.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

Veriheal

AUGUST 9, 2023

CBD, Trema micrantha, and the Study’s Significance CBD means cannabidiol , one of over a hundred compounds in the cannabis plant, and is widely celebrated as a potential treatment for a long list of health concerns, including chronic pain , epilepsy , i nsomnia , anxiety , and skin allergy.

CBD 96

CBD Cannabinoids THC Extraction 96

MedicalJane

MAY 21, 2020

Researchers at The University of New Mexico (UNM) have conducted a series of recent studies testing the effectiveness and safety of consuming cannabis, but this is the first study they have conducted measuring the therapeutic potential of hemp oil with low THC levels.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. A major oncology clinic aims to explore the efficacy and safety of cannabis to treat patients suffering from chronic pain.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

DECEMBER 28, 2021

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

Cannabis Law Report

OCTOBER 22, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. Cannabis oil: TO Pharmaceuticals TO Pharma is developing next-generation cannabinoid therapies for debilitating diseases.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

LifeCannMD

MARCH 3, 2025

Today, she maintains a discreet, effective regimen that has reduced her pharmaceutical intake by over half. Initially hesitant due to personal perceptions, Elena discovered marijuana THC edibles that transformed her treatment experience.

Edibles 52

Edibles Marijuana Dispensary Patients 52

Cannabis Law Report

OCTOBER 26, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., Chapman has operated Chapman Pharmaceutical Consulting, Inc., About MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

Cannabis Law Report

JANUARY 21, 2019

Britain tweaked legislation in November 2018 to allow specialist doctors in the UK to prescribe cannabis-based medicines to patients managing a wide range of symptoms – from chronic pain, chemotherapy-induced nausea and vomiting, to muscle spasticity for those with multiple sclerosis.

Chronic Pain 72

Chronic Pain Medicine Education Patients 72

MMJ Recs

JULY 11, 2024

Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers.

Sleep 111

Sleep Treatment Research and Development Therapy 111

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. As such, patients report reduced reliance on opioids and other pain medications, which often come with severe side effects.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

Cannabis Law Report

JANUARY 3, 2022

TASE: PNAX), a global pharma company that develops, manufactures and markets progressive cannabis-based products in pharmaceutical quality, announced today that it has received official approval for the EU-GMP standard for its production facility in Malta from EU Health Authority. SOURCE Panaxia Pharmaceutical Industries.

Pharmaceutical 52

Pharmaceutical Chronic Pain Extraction Epilepsy 52

Cannabis Law Report

MARCH 6, 2020

” In 2018, Europe was responsible for 23.2% of the world’s pharmaceutical sales with the size of the market in the EU-5 ( United Kingdom , Germany , Spain , France , and Italy ) set to grow by 25% between 2017 and 2022. It’s safety and efficacy have not been confirmed by FDA-approved research.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

Cannabis Law Report

FEBRUARY 25, 2019

A new legislative framework was also adopted by MPs, regulating cultivation, production, import and export of pharmaceutical cannabis and its use for in medical research, production of pharmaceuticals and the free prescription of pharmaceutical cannabis to eligible patients.

Medicine 63

Medicine Law Research and Development Pharmaceutical 63

Cannabis Law Report

JANUARY 19, 2022

AMP has entered into a three-year exclusive pharmaceutical distribution agreement for LGP Classic full-plant cannabis extract oils. Waldhausklinik is a non-profit acute care hospital for internal medicine in the Free State of Bavaria and has entered into a research collaboration with AMP into the efficacy and safety of medical cannabis.

Extraction 52

Extraction Oil Research and Development Medicine 52

SpeedWeed

AUGUST 26, 2021

Both Aurora and Ethypharm were chosen by the National Agency for Safety Medicines and Health Products (ANSM) to deliver dried flower for use by French patients. Combining our pharmaceutical skills is, in our view, the right approach to build trust and confidence in medical cannabis for the long term in France,” said Monin. “We

Chronic Pain 52

Chronic Pain Programs Patients Medicine 52

MMJ Recs

NOVEMBER 20, 2023

Therapeutic Effects of Cannabinoids Pain Relief: Perhaps one of the most recognized therapeutic effects of cannabinoids is pain relief. Both THC and CBD have demonstrated analgesic properties, making them valuable for managing chronic pain conditions such as arthritis, fibromyalgia, and cancer-related pain.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

NOVEMBER 2, 2020

The Australian Department of Health and parliament have not established a list of qualifying conditions, but are currently looking into research for conditions commonly treated with cannabis such as chronic pain, epilepsy, and multiple sclerosis amongst others.

Chronic Pain 52

Chronic Pain Strains Conditions Patients 52

Cannabis Law Report

OCTOBER 18, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. Lenabasum: Corbus Pharmaceuticals. Cannabis oil: TO Pharmaceuticals. INM-755: InMed Pharmaceuticals.

Research and Development 40

Research and Development Pharmaceutical Chronic Pain Therapy 40

SpeedWeed

MARCH 22, 2021

It went on to say: “The IASP has also published a list of research priorities which need to be addressed in order to properly determine the potential efficacy, and to confirm the safety of, cannabinoids when used in the treatment of pain.”. We want to give hope to the millions of people using opioids to treat chronic pain.”.

Business 52

Business Treatment Cannabinoids Medicine 52

The Cannigma

JUNE 16, 2022

Sure, it’s less addictive than some pharmaceutical drugs, with fewer side effects than most. A 2016 study of 176 medical patients found that six months of regular cannabis use improved pain symptoms, reduced the severity of pain, and helped patients become more functional in their daily lives. How cannabis can help seniors.

Terpenes 104

Terpenes Strains Sleep THC 104

Cannabis Law Report

DECEMBER 8, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. BERWYN, Pa.–(BUSINESS

Clinical Trials 40

Clinical Trials Chronic Pain Pharmaceutical Topical 40

Cannabis Law Report

DECEMBER 20, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., About Virpax Pharmaceuticals.

Clinical Trials 40

Clinical Trials Chronic Pain Pharmaceutical Data 40

Cannabis Law Report

NOVEMBER 10, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. as well as to support Good Laboratory Practices (GLP) toxicology, safety studies and preclinical efficacy studies. Envelta is Virpax’s endogenous enkephalin intranasal spray for acute and chronic pain, including pain associated with cancer.

Research and Development 40

Research and Development Chronic Pain Pharmaceutical Clinical Trials 40

Cannabis Law Report

JUNE 26, 2019

Fried also strongly delivered a message that could have been taken straight out of my own mouth: “This is a plant that not only improves people’s quality of life, it’s an alternative to sometimes-dangerous pharmaceuticals and addictive opioids.” Heather also acts as a Junior Pain Ambassador with the U.S.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Healer

DECEMBER 17, 2021

Cannabidiol (CBD) is a well-known component of hemp with diverse health benefits such as reducing pain and inflammation after physical activity, relief from occasional sleeplessness, as well as improvements in focus, mood and resilience to stress. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.).

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Events 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Pain and chronic pain were the most common conditions mentioned over the time period and were referred to in 62% of all articles.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 14, 2019

This is a plant that not only improves people’s quality of life, it’s an alternative to sometimes dangerous pharmaceuticals and addictive opioids. Michelle Weiner is certified in Interventional Pain Management and Physical Medicine and Rehabilitation. David Kotler is a partner in Cohen Kotler P.A.

Agriculture 40

Agriculture Marijuana Research and Development Policy 40

PrestoDoctor

JUNE 7, 2023

They can reduce pain levels associated with migraines without producing unwanted side effects. This offers a natural, sustainable relief in place of pharmaceutical options like opioids or other medications. Marijuana strains with the right combination of cannabinoids show potential. 1 in 7 individuals have experienced a migraine.

Research and Development 52

Research and Development Indica Strains Sleep 52

PrestoDoctor

JUNE 7, 2023

They can reduce pain levels associated with migraines without producing unwanted side effects. This offers a natural, sustainable relief in place of pharmaceutical options like opioids or other medications. Marijuana strains with the right combination of cannabinoids show potential. 1 in 7 individuals have experienced a migraine.

Research and Development 52

Research and Development Indica Strains Sleep 52

Cannabis Law Report

MAY 13, 2019

“There’s still a lot we don’t know about medicinal cannabis … when it comes to the pharmacology, what does it do on a molecular level and how does it affect things like chronic pain or symptoms of MS [multiple sclerosis]?”. A public vote saw the State of California approve the use of medicinal cannabis in 1996.[

Medicine 45

Medicine Research and Development Clinical Trials Data 45